Prognostic Impact of Major Pathologic Response After Preoperative Treatment in Resected Pancreatic Ductal Adenocarcinoma

20260 citationsJournal Articlehybrid Open Access

Authors

Kei Yamane · Kyoto University

Kazuyuki Nagai · Kyoto University

Takayuki Anazawa · Kyoto University

Yosuke Kasai · Kyoto University

A. Sato · Kyoto University

Yu Hidaka · Kyoto University

Yumiko Ibi · Kyoto University

Abstract

MPR was independently associated with favorable survival in PDAC. The prognostic impact of adjuvant chemotherapy was not observed among patients who achieved MPR, suggesting that MPR may inform individualized postoperative management and warrants prospective validation.

Topics & Keywords

Pancreatic and Hepatic Oncology Research Esophageal Cancer Research and Treatment Lung Cancer Diagnosis and Treatment

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Annals of Surgery

DOI: 10.1097/sla.0000000000007052

Field-Weighted Citation Impact: 0.00